To increase the number of livers available for transplantation a non-heartbeating donor (NHBD) liver transplant program was started after obtaining hospital ethical committee approval. Methods: Controlled donors with a warm ischemia of Ͻ30 minutes were considered. A 5-minute stand-off period was observed from asystole to skin incision. A super-rapid technique was used for the retrieval. Methods used to assess the suitability for transplantation included liver function tests, morphologic and histologic assessment, and hepatocyte viability testing. Results: Sixty livers were retrieved from NHBDs. Of these, 33 were judged suitable for transplantation. Of these one was exported and transplanted, and one could not be matched to a suitable recipient. A further 27 were not used because of liver appearance in 21, prolonged hypoxia and hypotension in 4, poor perfusion in 1, and donor malignancy in 1. Mean donor age was 39.4 years (range, 0.75-67 years). Causes of death were head trauma in 10 donors, intracranial bleed in 24, and anoxic/ischemic brain injury in 26. Mean warm ischemia time was 14.7 minutes (range, 7-40 minutes). Thirty-two patients were transplanted (one split liver), and the mean age of the recipients was 38.4 years (range, 0.7-72 years). All grafts had good early function except one right lobe split. There were 4 deaths resulting from ischemic brain injury, chronic rejection, biliary sepsis, and multiorgan failure following retransplantation for primary nonfunction. Overall patient and graft survival is 87% and 84%, respectively, at a median follow-up of 15 months. Conclusions: Early results suggest that controlled NHBDs are a significant new source of grafts, but careful donor selection and short cold ischemia are mandatory.
T he demand for liver transplantation (OLT) has led to an increasing discrepancy between the number of potential candidates and organ availability. Diverse strategies have been successfully implemented to try to improve organ supply including the use of marginal, split, living, and domino donor grafts. Following the successful use of kidney grafts from non-heartbeating donors (NHBDs) for transplantation, 1 interest has extended to include the liver, pancreas, and lung. 2, 3 NHBDs are patients with brain injury incompatible with recovery whose condition does not meet formal criteria for brainstem death and whose cardiopulmonary function ceases before organs are retrieved. In the 1960s, NHBDs were the main source of allografts until the Harvard neurologic definition and criteria for brain death were published in 1968. Following the introduction of brainstem death criteria, interest in NHBD declined because of the better results obtained with heartbeating donor organs. Renewed interest in NHBDs as a source of organs has occurred because of organ shortage and improvements in organ preservation, immunosuppression, and surgical techniques.
NHBD can be categorized into 2 groups: controlled and uncontrolled donors. Controlled donation takes place when the death occurs within an intensive care unit (ICU)/hospital setting and there is planned withdrawal of therapy by the patient's medical team. Uncontrolled donation takes place when death occurs outside the hospital or within the emergency room and resuscitation is continuing and is unpredictable. The ethics, assessment, techniques of retrieval, and outcome of transplant are very different between these 2 groups.
NHBDs have been further categorized into 4 groups 4 according to the location and modality of death. Experience of NHBD kidney transplants has shown no difference in the long-term outcome of kidney grafts from NHBD and brain dead donors, although the incidence of delayed function is significantly higher in the former. [5] [6] [7] Whereas these patients can be managed with dialysis, this is not possible with the liver recipients and if primary nonfunction (PNF) or severe dysfunction occur, emergency retransplantation is the only rescue therapy. There have been relatively few reports regarding OLT from NHBDs, but these have shown a progressive reduction in the incidence of PNF in recent years due to a shift towards controlled donation and restriction of donor selection criteria with shorter warm and cold ischemic times. 8, 9 In 2001, a NHBD liver transplant program was started on the background of a long-standing non-heartbeating kidney transplantation program based in our region since 1988. A protocol for liver retrieval and evaluation of controlled NHBD livers was developed, and hospital ethical committee approval was obtained in our institution and in prospective donor hospitals in our retrieval zone.
METHODS
Between May 2001 and May 2004, 584 livers were procured in our retrieval zone. Of these, 58 (9.9%) were obtained from NHBDs. Two further NHBD hepatic allografts were imported from other transplant centers. Data were collected prospectively in a database at our institution.
Donors and Recipients
A standardized protocol for the transplantation of livers from NHBDs was developed and used from the start of the program. Only Maastricht category III and IV controlled donors less than 50 years of age were considered at first, but after the initial good results the age parameter was loosened up to 65 years. Category IV were brain dead donors where the family agreed to organ donation provided it was carried out after withdrawal of cardiac and respiratory support and subsequent cardiac arrest. Although we occasionally retrieved organs from uncontrolled category IV donors, it was not performed within a structured NHBD program and these donors were not included in our present series.
Category III donors were patients in ICUs where withdrawal of treatment had been planned on medical grounds. They were considered for liver donation provided they had good liver and renal function and after explicit consent had been obtained from relatives. Coroners' approval was acquired where appropriate. A minimum waiting period of 5 minutes after cardiac arrest was observed before starting the retrieval procedure following the recommendations of the Institute of Medicine. 10 The transplant team was not involved in decisions regarding the modality and logistics of withdrawal, and these were undertaken by the intensive care physician and according to local hospital policies. Similarly, the transplant team was not involved in the declaration of death.
Patients were offered livers from NHBD based on clinical urgency (decompensation or hepatocellular carcinoma) and were counseled based on published experience. No restriction was applied to the choice of prospective recipient.
Clinical review after the first 20 liver transplants led to a formal consent form approved by UK Transplant, and currently NHBD is routinely discussed and offered to all recipients accepted onto the waiting list.
Our standard immunosuppressive regimen was based on low-dose prednisolone and tacrolimus. Post-transplant management was according to standard protocols.
Surgical Retrieval Procedure
The procedure is a modification of the super rapid technique described by Casavilla et al. 3 The surgical set has been adapted and simplified for a quick setup and draping. The preservation fluids used are Marshall's solution to flush the aorta and University of Wisconsin (UW) solution for portal perfusion. Heparin (20,000 units) is added to the first liter of both perfusion solutions.
The aorta is accessed first via a full-length midline laparotomy incision and a large bore (size no. 20) cannula is inserted and secured for perfusion with low-viscosity Marshall's solution. Topical cooling is achieved with normal saline slush. A rapid thoracotomy is performed, and congestion in the area of the inferior vena cava (IVC) is relieved by drainage through a large incision in the right atrium. Next a large clamp is applied to the aorta just above the diaphragm.
In the most recent donor procedures performed, the IVC is drained immediately with a Foley catheter at the iliac confluence to avoid excessive congestion of the abdominal organs.
The superior mesenteric vein (SMV) is then identified and cannulated and portal perfusion commenced with UW solution. The first liters of both Marshall's and UW solutions are perfused under mild pressure (40 -60 mm Hg). The procedure continues in a similar manner to a conventional retrieval, and care is taken not to divide possible anomalous hepatic or renal vessels, more difficult to identify without a pulse.
Evaluation of the Graft
Suitability of the NHBD livers for transplantation is initially assessed at retrieval. Factors considered in making the decision include the time between withdrawal of therapy and death and the period of warm ischemia, defined as the interval from hypotension (systolic blood pressure of less than 50 mm Hg) to aortic perfusion with cold preservation solution. Warm ischemia includes the time of declaration of death and the stand off period.
If cardiac arrest does not occur within 1 hour of withdrawal, liver retrieval is abandoned and the kidneys alone are retrieved. The liver is assessed macroscopically for the presence of fatty change, perfusion quality, physical characteristics, and weight. Frozen section histology of Trucut liver biopsies is performed and assessed prior to a decision being made to transplant the liver. Routine histology and hepatocyte viability are also carried out on all NHBD livers to evaluate their potential contribution to the graft assessment. Following the decision to use the NHBD liver, every effort is made to reduce the period of cold ischemia to a minimum.
Hepatocyte Viability
Both transplanted and unused grafts are assessed for hepatocyte viability at similar cold ischemia times. A mechanical digestion technique is used on wedge biopsies of transplanted livers. For discarded grafts, a collagenase perfusion technique, according to Strom et al 11 is used to isolate hepatocytes. The technique involves the use of a chelating agent (EGTA) to disaggregate hepatocytes, while the main step involves the use of collagenase P and DNaseI enzymes to digest the tissue. The hepatocytes are washed and purified using a low-speed centrifugation process. The isolated hepa- 
RESULTS

Characteristics of the Donors
Over a 3-year period, 60 livers were retrieved from NHBD. Of these, 2 were imported from other transplant centers in the United Kingdom. In 6 instances, the patient's heart did not arrest within 60 minutes from withdrawal of treatment and the liver was not retrieved.
Of the 60 NHBD livers, 27 (45%) were considered not to be transplantable because of the appearance in 21 (steatosis in 17, abnormal consistency in 4), prolonged hypoxia and hypotension post withdrawal of therapy in 4, poor graft perfusion in 1, and donor malignancy in 1. Thirty-one livers were transplanted at King's College Hospital. Of the 2 further grafts judged transplantable, one was exported and transplanted in another center, and no suitable recipient was identified for the other.
Mean donor age was 39.4 years (range, 0.75-67 years), and 38 were males. Twenty-four donors had an intracranial bleed, 10 had head trauma, and 26 had ischemic/anoxic brain injury. The average ICU stay was 3.8 days (range, 1-14 days). The mean warm ischemia time was 14.7 minutes (range, 7-40 minutes).
A comparison of the transplanted grafts with those not used for solid organ transplantation showed no significant differences in donor characteristics, length of ICU stay, inotrope requirements, liver function, and warm ischemia ( Table 1 ).
Characteristics of the Recipients
Thirty-one livers were used for 32 transplants, which included 25 whole livers and 7 segmental grafts; of these, 2 were right lobes (one split and one partial orthotopic auxiliary graft), 4 left lateral segments (3 reduced and one split graft), and one left lobe reduced liver. The indications included viral hepatitis in 15, familial amyloid polyneuropathy in 2, primary sclerosing cholangitis in 2, acute liver failure in 2, autoimmune hepatitis in 2, malignancy in 3, and in the remaining 6, alcoholic liver disease, cryptogenic cirrhosis, factor VII, factor VIII deficiency, primary hyperoxaluria type I, and neonatal sclerosing cholangitis, respectively. The average age of the recipients was 38.4 years (range, 0.7-72 years) and 20 were males. Two patients, with hepatitis C-related and cryptogenic cirrhosis, had aortic valve replacements at the time of transplant. The average warm ischemia of the transplanted grafts was13.9 minutes (range, 7-31 minutes) and the cold ischemia time 8.6 hours (5.2-14.3 hours).
The mean operative time was 5.4 hours (range, 3.7-8 hours) and mean blood loss was 3273 mL (range, 300 -9864). Early reperfusion hypotension was prominent in all patients and 19 (59%) patients required transitory cardiovascular support with vasopressors post reperfusion. By the end of the procedure, only 6 patients needed inotropic support; otherwise, the reperfusion injury was relatively short lived. Mean lactate values were 3.6 mmol/l (range, 1.0 -17.9 mmol/l) pre-reperfusion, 4.7 mmol/l (range, 1.8 -16.9 mmol/l) at 30 minutes post reperfusion, 2.9 mmol/l (range, 1-6 mmol/l) at 120 minutes, and 1.8 mmol/l (range, 0.9 -4.5 mmol/l) at day 1 post-transplantation.
Postoperatively at day 1 and at day 7, the median AST values were 1376 IU/L (range, 237-13,886 IU/L) and 65 IU/L (range, 30 -730 IU/L) and the INR values were 1.4 (range, 1.01-2.6) and 1.06 (range, 0.93-1.79), respectively. Nine patients (28.1%) had at least one episode of biopsyproven rejection and responded to high-dose steroids. One patient had a second episode of rejection and responded to a second course of high-dose steroids and daclizumab. The median hospital stay post-transplantation was 21 days (range, 12-92 days). Details of the transplant recipients are listed in Table 2 .
There were 3 vascular complications, which included one venous outflow obstruction after a piggyback procedure, successfully managed with endovascular stenting, a hepatic artery thrombosis (HAT) at 1-week post-transplantation, which required urgent retransplantation and an early thrombosis of the right hepatic artery, which did not compromise graft function. However, this patient developed an extrahepatic biliary stricture 7 months post-transplantation, which was endoscopically stented. Two further recipients developed biliary complications (9.4%). One was diagnosed a mild anastomotic stricture with a low-grade intrahepatic cholangiopathy, which did not require intervention. The second patient had an anastomotic stricture dilated and stented at endoscopic retrograde cholangiopancreatography.
Two livers were lost in the perioperative period, including a right lobe split graft due to PNF and a whole liver from the above-mentioned HAT. One graft developed peripheral venous infarction but maintained good function and the CT changes resolved.
There were 4 deaths. One patient transplanted for acute liver failure secondary to paracetamol intoxication died 11 days post-transplantation from sepsis and severe multiorgan failure with evidence of ischemic brain injury. One patient died of chronic rejection 7 months post-transplantation, having been noncompliant with his immunosuppression therapy. The patient who received a split right lobe graft and was retransplanted for PNF died 9 days after the second transplant from sepsis and multiorgan failure. The fourth death was due to biliary sepsis in a 50-year-old patient with a biliary stricture secondary to segmental right arterial HAT 2 years posttransplantation. She had concomitant diabetes and chronic renal failure and developed intractable sepsis. The actuarial 1-year patient and graft survival is 89.6% and 86.5%, respectively, and the mean follow-up post-transplantation 14.7 months (range, 1-40 months) (Fig. 1) .
The livers retrieved from NHBDs, but not transplanted, were perfused using a 2-stage collagenase perfusion tech-nique followed by centrifugal purification of hepatocytes. Wedge biopsies from the transplanted grafts were mechanically digested with collagenase. Average hepatocyte viability rates were 55% for the livers not used for transplantation and 70% for grafts that were transplanted (P ϭ 0.01). No other differences between the used and discarded grafts were noted in terms of age of the donor, ICU stay, liver function, and warm and cold ischemia (defined for the unused livers as the time from liver in ice to the collagenase perfusion) ( Table 1) .
DISCUSSION
Liver transplantation from cadaveric heart beating donation (HBD) has achieved excellent results worldwide with 1-year patient survival for chronic liver disease of greater than 80%. However, in recent years, data from UK Transplant have shown an increase in the number of patients dying while on the transplant list and of patients removed from this list. The disparity between demand for liver grafts and the supply continues to widen in the United Kingdom, continental Europe, and North America. 12 Split liver transplantation has been a very effective tool in reducing the mortality on the pediatric list while sustaining adult numbers. Adult-to-adult live donation, the main source of liver grafts in Japan, has increased in Europe and the United States but is associated with problems for the recipients with small for size syndrome and donor mortality of 0.5% and morbidity of 10% to 20%. The shortage of organs has led centers to expand their criteria for the acceptance of marginal donors including older donors, steatotic livers, donors with viral hepatitis, and non-heartbeating donors.
Prior to brain death legislation, NHBD was the only source of cadaveric organs for transplantation. However, with the advent of brainstem testing, the superior results of transplantation of organs from heartbeating donors led to a loss of enthusiasm and expertise in non-heartbeating retrieval. Interest in NHBDs has revived because of the shortage of organs and also the successful use of kidneys from this source.
Uncontrolled donors are victims of unexpected cardiorespiratory arrest, which occurs either within or outside the hospital and in whom resuscitation attempts have failed to restore cardiac function. In this scenario, contacting the family promptly and obtaining their decision on organ donation may prove extremely difficult. Nonconsensual preservation methods, although maintaining the option for organ donation to relatives, are still debated as they may produce antipathy in society toward NHBD. The circumstantial events and medical status of those who suffer unexpected cardiopulmonary arrest are greatly varied so that it is more difficult to propose a uniform approach to the determination of death in the uncontrolled NHBD. The design of clear protocols concerning the vigor and duration of attempts to restore circulation, the standards of determining death and the timing of organ removal, is essential to reduce to a minimum the potential conflict of interest between resuscitation of the patient and organ donation. These ethical issues still constitute one of the main hurdles to the wider acceptance of uncontrolled NHBD. Controlled donation presents a different set of problems. The decision to donate follows on from and is independent of the planned withdrawal of treatment and occurs within a hospital environment. The ethical issues of controlled NHBD also include questions regarding the ambiguity and cultural perspective of death, and the potential use of premortem procedures or medications that subordinate the interest of the patient to that of organ preservation.
Perhaps the greatest ethical question with NHBDs is measuring the period of suspension between life and death. A standoff time is observed from the time of cardiac arrest to establish the demarcation between an individual's status changing from that of a dying patient to that of a donor. Various protocols observe different times including 2 minutes (Pittsburgh protocol), 5 minutes (Institute of Medicine), and 10 minutes (Maastricht Statements and Recommendations). This period is observed to preclude any possibility of spontaneous return of the circulation and to allow death to be pronounced with confidence.
If not meticulously addressed, ethical concerns could potentially damage the public trust toward transplantation and may produce a negative effect on all organ donation rates.
Broad and unambiguous guidelines should be produced to increase the understanding and acceptance by the public. 13 The main difficulty with NHBD is the inevitable period of warm ischemia, which may adversely affect tissue viability and graft function after transplantation. Although warm ischemic injury per se does not preclude successful transplantation, reduced tolerance to subsequent cold storage of organs from NHBDs has been demonstrated when compared with grafts from heartbeating donors. 14 Kidneys can withstand longer periods of cold ischemia and in cases of delayed graft function, renal replacement therapy provides a safety net. However, severe graft dysfunction or PNF, following OLT, invariably leads to emergency retransplantation or death. Early reports of liver transplantation from NHBDs revealed a high incidence of PNF and hepatic artery thrombosis with 1-year graft survival of less than 50%. 3 Short-term results with transplantation of livers and kidneys from uncontrolled NHBDs carry a significantly higher incidence of PNF or graft dysfunction. The shift in use of controlled NHBD and increasing experience in donor selection have led to progressive and significant improvement in early outcome after OLT with PNF rates and graft survival approaching that of heartbeating donation. 8, 9 These results are confirmed by our experience of good early graft function in all the patients transplanted but one, who received a right lobe split with a cold ischemic time of 14.3 hours. The left lateral segment split graft was transplanted first with 7 hours of cold ischemia and provided excellent immediate function with an International Normalized Ratio of 1.2 on the second postoperative day. It has been reported that NHBD liver grafts are more susceptible to cold ischemia as these are preceded by a period of warm ischemia and that every effort should be made to minimize cold storage time. 14 We showed the feasibility of segmental liver transplantation of NHBD liver grafts in children. Our group reported the first cut down of a NHBD liver for a child who received a right lobe orthotopic auxiliary graft for seronegative acute liver failure and who is alive and well at 1-year follow-up. 15 Although the incidence of delayed graft function is significantly higher with kidneys from NHBDs than with kidneys from donors with a heartbeat, there is no difference in long-term outcome between the 2 sources. No comparable data are as yet available for NHBD livers as the numbers are very limited. The largest retrospective study comparing outcomes of adult recipients of NHBD and heartbeating donation hepatic allografts between 1993 and 2001 using the United Network of Organ Sharing database showed a lower graft survival among a group of 144 NHBD livers and confirmed their greater vulnerability to cold ischemia and the higher incidence of PNF. 16 Abt et al suggested that livers from NHBDs are also more susceptible to biliary complications and have reported a high incidence of ischemic cholangiopathy. 17 There is experimental evidence that irreversible intrahepatic biliary lesions develop as a consequence of the warm ischemia; however other factors, which influence microcirculatory function, are also likely to be important. 18 The higher incidence reported was not observed in our experience, with only 3 of the 32 recipients developing a biliary complication. One of these 3 patients has developed a mild intrahepatic cholangiopathy, which has not required intervention, but he remains under close follow-up. Our mean follow-up of 15 months is shorter, but our lower rate of PNF of 3% and of biliary problems (9.3%) may reflect differences in donor selection and retrieval.
To improve the quality of organ perfusion, we doubled the amount of heparin in the perfusion fluids and introduced pressure bags to increase the perfusion pressure of the preservation fluid in aorta. Experimental work has also concentrated on the use of fibrinolytic substances such as streptokinase used as a preflush, 19 which may be of value considering that in one third of NHBD retrievals there were visible clots in the aorta at cannulation. Gok et al reported good results in clinical practice with the use of streptokinase preflush in NHBD kidney procurement. 20 Currently in the United Kingdom, administering heparin and/or vasodilators prior to cardiac arrest is not an accepted practice as it is not in the best interest of the dying patient but for the exclusive benefit of the potential recipient. In the United States, several centers support the use of these drugs prior to withdrawal of support, if there is no clear evidence that it will hasten death.
Although lower tolerance to cold storage limits the exchange of NHBD livers between transplant centers, this has been successfully done but requires a more efficient and rapid referral system.
The renewed interest in NHBD has stimulated further research in ischemia/reperfusion and new preservation techniques. There is evidence that preservation times will be extended by the provision of continuous cellular substrate. Stimulation of in vivo conditions by ex vivo perfusion could also mean that marginal organs could be resuscitated for transplantation. 21 Cold machine perfusion currently offers the possibility of assessing the suitability of kidneys before transplantation. 22 Extracorporeal graft perfusion techniques Annals of Surgery • Volume 242, Number 5, November 2005 Liver Transplantation and Non-Heartbeating Donors could potentially reduce the risk of PNF, extend graft preservation times, and expand the use of NHBD to thoracic organs, particularly to the lungs. Although it seems that hepatocyte viability testing may represent a useful tool, further experience is needed in this field to evaluate its potential in assessing the suitability of livers from this source for transplantation. Expansion of the donor pool is urgently needed since alternative solutions, such as xenotransplantation, artificial organs, and stem cell transplantation, remain experimental and are not likely to make an impact on clinical practice in the immediate future. Despite a higher level of delayed graft function, the results from non-heartbeating renal transplantation are excellent, with long-term function comparable to cadaveric organs. Short-term results with NHBD liver transplantation are improving, but more data are needed on the longer-term outcome. Techniques, such as machine perfusion preservation, may further improve the results from nonheartbeating renal and extrarenal programs. The use of NHBDs has the potential to increase donation of kidneys by at least 20% 23 and liver by as much as 10% in the next 3 to 5 years.
